Michael Arnold

Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver, Stanford University

Environmental ScienceMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group”.

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group

The Lancet Oncology(2024)10.1016/s1470-2045(24)00255-9

N/A

0.907DataRank · unranked

43 citations

Wei Xue, Douglas J Harrison, Douglas S. Hawkins, Roshni Dasgupta, Suzanne Wolden +10 more

Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group

Cancer(2023)10.1002/cncr.34723

N/A

0.509DataRank · unranked

12 citations

Wei Xue, Zhengya Gao, Ralph P. Ermoian, Julie A. Bradley, Michael Arnold +4 more

Ribonucleotide reductase, a novel drug target for gonorrhea

eLife(2022)10.7554/elife.67447

N/A

0.406DataRank · unranked

14 citations

Suzanne Letinski, Stephen P. Jung, Aleksey Gerasyuto, Jiashi Wang, Michael Arnold +11 more

Hybridization in human evolution: insights from other organisms

10.31730/osf.io/y3bp7

N/A

0.250DataRank · unranked

3 citations

Michael Arnold, Marcella Baiz, James A Cahill, Liliana Cortés-Ortiz, Ben J Evans +16 more

Cytotoxic T-Lymphocyte-Associated Antigen 4 Haploinsufficiency Mimics Difficult-to-Treat Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.05.001

N/A

0DataRank · unranked

1 citations

Cullen M. Dutmer, Michael Arnold, Caroline Hall, Jordan K. Abbott, Edwin F. de Zoeten +1 more

Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostin

Journal of Allergy and Clinical Immunology(2022)10.1016/j.jaci.2022.03.022

N/A

0DataRank · unranked

50 citations

Steven J. Ackerman, Zhaoxing Pan, Alain Benitez, Cassandra Burger, Jonathan M. Spergel +8 more

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis

European Journal of Cancer(2022)10.1016/j.ejca.2022.03.022

N/A

0DataRank · unranked

31 citations

Rajkumar Venkatramani, Anton Schönstein, Svetlana Pack, Rita Alaggio, Christian Vokuhl +13 more

MYOD1 as a prognostic indicator in rhabdomyosarcoma

Pediatric Blood & Cancer(2021)10.1002/pbc.29085

N/A

0DataRank · unranked

15 citations

Sultan S. Habeebu, Midhat S. Farooqi, Alan S. Gamis, Elizabeth M. Gonzalez, Terrie Flatt +9 more

Joint effects of general population polygenic risk scores (PRS) and radiation treatment on subsequent neoplasm risk among childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10008

N/A

0DataRank · unranked

1 citations

Danielle M. Karyadi, Vidushi Kapoor, Michael Arnold, Amy Berrington de González, Ravi Bhatia +11 more

Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low‐risk clinical trials: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2021)10.1002/pbc.28914

N/A

0DataRank · unranked

19 citations

Wei Xue, Joshua D. Palmer, David Walterhouse, Michael Arnold, Todd E. Heaton +2 more

Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study

PLoS ONE(2020)10.1371/journal.pone.0228887

N/A

0DataRank · unranked

26 citations

Philip J. Lupo, Lindsay M. Morton, Yutaka A. Yasui, Yadav Sapkota, Michael Arnold +12 more

Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors

Nature Medicine(2024)10.1038/s41591-024-02837-7

N/A

0DataRank · unranked

15 citations

Danielle M. Karyadi, Stephen W. Hartley, Michael Arnold, Amy Berrington de González, Miriam Conces +10 more

Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Pediatric Blood & Cancer(2024)10.1002/pbc.30847

N/A

0DataRank · unranked

11 citations

Amira Qumseya, Wei Xue, Michael Arnold, Timothy B. Lautz, Susan M. Hiniker +5 more

Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies

Pediatric Blood & Cancer(2024)10.1002/pbc.31200

N/A

0DataRank · unranked

1 citations

Wei Xue, Amira Qumseya, Leo Y. Luo, Susan M. Hiniker, Timothy B. Lautz +4 more

MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLD

iScience(2025)10.1016/j.isci.2025.113149

N/A

0DataRank · unranked

2 citations

Peter Y. Yu, Abasi-ama Udeme, Sudarshana M. Sharma, Priya Londhe, Benjamin R. Pryce +12 more

Temporal trends of subsequent central nervous system malignancies among survivors of childhood cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf005

N/A

0DataRank · unranked

0 citations

Yan Chen, Yan Yuan, Tabitha Cooney, Rebecca M. Howell, Susan A. Smith +7 more

The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children’s Oncology Group

Human Genetics and Genomics Advances(2025)10.1016/j.xhgg.2025.100466

N/A

0DataRank · unranked

0 citations

Christina L. Magyar, Bailey A. Martin‐Giacalone, Michael E. Scheurer, Deborah A. Marquez-Do, Mark Zobeck +17 more

Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Cancer(2020)10.1002/cncr.33334

N/A

0DataRank · unranked

36 citations

Yueh‐Yun Chi, Rajkumar Venkatramani, Minjie Li, Michael Arnold, Roshni Dasgupta +4 more